SCHEMBL25029256

SCHEMBL25029256

c1ccc2nc(-c3n[nH]c4cc(N5CCOCC5)ccc34)ccc2c1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 5/20 0.60
▸ KDM4E B2RXH2 4/20 0.60
▸ NPC1 O15118 3/20 0.60
▸ RAB9A P51151 3/20 0.60
▸ L3MBTL1 Q9Y468 3/20 0.60
▸ GAA P10253 2/20 0.60
▸ SMN1; SMN2 Q16637 2/20 0.60
▸ ITK Q08881 1/20 0.58
▸ FGFR1 P11362 3/20 0.57
▸ FLT1 P17948 2/20 0.57
▸ LRRK2 Q5S007 3/20 0.50
▸ ALDH1A1 P00352 2/20 0.46
▸ AHR P35869 1/20 0.46
▸ HPGD P15428 1/20 0.46
▸ MAPK1 P28482 1/20 0.46
▸ TDP1 Q9NUW8 1/20 0.46
▸ HCRTR1 O43613 1/20 0.46
▸ LMNA P02545 1/20 0.46
▸ XBP1 P17861 1/20 0.44
▸ KLF5 Q13887 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25027581 0.92 KDM4E (0.59) MAPTKDM4ENPC1RAB9AL3MBTL1
SCHEMBL29363709 0.74 FGFR1 (0.55) KDM4ENPC1RAB9AGAASMN1; SMN2
SCHEMBL2189184 0.74 FGFR1 (0.55) KDM4ENPC1RAB9AGAASMN1; SMN2
SCHEMBL25029012 0.72 ITK (0.43) MAPTKDM4ENPC1RAB9AL3MBTL1
SCHEMBL29363797 0.72 ITK (0.43) MAPTKDM4ENPC1RAB9AL3MBTL1
SCHEMBL29548155 0.72 LRRK2 (0.72) MAPTKDM4ENPC1RAB9AL3MBTL1
SCHEMBL26911852 0.72 LRRK2 (0.72) MAPTKDM4ENPC1RAB9AL3MBTL1
SCHEMBL3533364 0.72 FGFR1 (0.85) ITKFGFR1FLT1LRRK2
SCHEMBL29005658 0.71 KDM4E (0.52) MAPTKDM4ENPC1RAB9AL3MBTL1
Hydrochloric Acid SCHEMBL28750190 0.71 MAPT (0.61) MAPTKDM4ENPC1RAB9AL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12448368-B2 Indole compounds as androgen receptor modulators NIDO BIOSCIENCES, INC. (US) 2025-10-21 — — US disclosed
US-20250122176-A1 INDOLE COMPOUNDS AS ANDROGEN RECEPTOR MODULATORS NIDO BIOSCIENCES INC (US) 2025-04-17 — — US disclosed
US-20250092021-A9 INDOLE COMPOUNDS AS ANDROGEN RECEPTOR MODULATORS NIDO BIOSCIENCES, INC. 2025-03-20 — — US disclosed
US-20230348439-A1 INDOLE COMPOUNDS AS ANDROGEN RECEPTOR MODULATORS NIDO BIOSCIENCES INC (US) 2023-11-02 — — US disclosed
US-20230348439-A1 INDOLE COMPOUNDS AS ANDROGEN RECEPTOR MODULATORS NIDO BIOSCIENCES INC (US) 2023-11-02 — — US disclosed
US-20230348439-A1 INDOLE COMPOUNDS AS ANDROGEN RECEPTOR MODULATORS NIDO BIOSCIENCES INC (US) 2023-11-02 — — US disclosed
US-11667624-B2 Indole compounds as androgen receptor modulators NIDO BIOSCIENCES, INC. (US) 2023-06-06 — — US disclosed
US-11667624-B2 Indole compounds as androgen receptor modulators NIDO BIOSCIENCES, INC. (US) 2023-06-06 — — US disclosed
US-11667624-B2 Indole compounds as androgen receptor modulators NIDO BIOSCIENCES, INC. (US) 2023-06-06 — — US disclosed
EP-4182320-A1 INDOLE COMPOUNDS AS ANDROGEN RECEPTOR MODULATORS Nido Biosciences, Inc. (US) 2023-05-24 — — EP disclosed
CN-115996926-A Indole compounds as androgen receptor modulators 尼多生物科学有限公司 2023-04-21 — — CN disclosed
US-20230049406-A1 INDOLE COMPOUNDS AS ANDROGEN RECEPTOR MODULATORS NIDO BIOSCIENCES, INC. 2023-02-16 — — US disclosed
US-20230049406-A1 INDOLE COMPOUNDS AS ANDROGEN RECEPTOR MODULATORS NIDO BIOSCIENCES, INC. 2023-02-16 — — US disclosed
WO-2022020342-A1 INDOLE COMPOUNDS AS ANDROGEN RECEPTOR MODULATORS NIDO BIOSCIENCES, INC. (US) 2022-01-27 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230049406-A1 INDOLE COMPOUNDS AS ANDROGEN RECEPTOR MODULATORS AR, FSHR, NR5A1 MAPT 735/4885KDM4E 1654/4885NPC1 332/4885
US-20230348439-A1 INDOLE COMPOUNDS AS ANDROGEN RECEPTOR MODULATORS AR, FSHR, NR5A1 MAPT 682/4885KDM4E 1443/4885NPC1 314/4885
US-20250122176-A1 INDOLE COMPOUNDS AS ANDROGEN RECEPTOR MODULATORS AR, FSHR, NR5A1 MAPT 735/4885KDM4E 1654/4885NPC1 332/4885
US-11667624-B2 Indole compounds as androgen receptor modulators AR, FSHR, ADRB3 MAPT 682/4885KDM4E 1533/4885NPC1 371/4885
US-20250092021-A9 INDOLE COMPOUNDS AS ANDROGEN RECEPTOR MODULATORS AR, FSHR, NR5A1 MAPT 735/4885KDM4E 1654/4885NPC1 332/4885
US-12448368-B2 Indole compounds as androgen receptor modulators AR, FSHR, ADRB3 MAPT 682/4885KDM4E 1533/4885NPC1 371/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback